C84.45
Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of inguinal region and lower limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Peripheral T-cell lymphoma is a type of non-Hodgkin lymphoma that originates from mature T-lymphocytes, which are a form of immune cells. The specific diagnosis of ICD-10 code C84.45 refers to a subtype that affects lymph nodes in the inguinal region (groin area) and lower limbs. This form of lymphoma is considered rare and requires specialized treatment. It is characterized by abnormal growth of T-cells in specific lymph nodes, leading to swelling and other health issues. Early diagnosis and understanding of this disease are essential for appropriate management and improving quality of life.
Causes & Symptoms
Clinical Causes: Genetic mutations that affect T-cell development and function Environmental factors such as exposure to certain chemicals or toxins Viral infections, particularly Epstein-Barr virus (EBV) or Human T-lymphotropic virus (HTLV-1) Immune system dysfunction or suppression Previous history of other lymphoid cancers or autoimmune conditions
Key Symptoms: Swelling and palpable lumps in the inguinal area or along the legs Persistent or unexplained weight loss Fever that does not resolve with typical treatments Night sweats Fatigue or weakness Skin lesions or irritations near the affected lymph nodes Itching or discomfort in the affected regions Rarely, systemic symptoms such as malaise or loss of appetite
Diagnostic & Treatment
Diagnosis Path: The diagnosis involves a combination of clinical evaluation, imaging studies, and laboratory tests. Steps include: - Physical examination focusing on lymph node swelling in the inguinal and lower limb regions - Imaging techniques such as computed tomography (CT), positron emission tomography (PET), or magnetic resonance imaging (MRI) to assess the extent of disease - Biopsy of affected lymph nodes to examine tissue under a microscope - Immunohistochemistry to identify the specific type of lymphoma cells - Blood tests to evaluate overall health and immune function - Bone marrow biopsy in some cases to check for spread of lymphoma The pathological examination confirms the diagnosis as peripheral T-cell lymphoma, not elsewhere classified, with a focus on lymph nodes of the inguinal region and lower limbs.
Treatment Protocols: Treatment strategies depend on the stage and characteristics of the lymphoma but generally include: - Chemotherapy to destroy cancerous T-cells - Radiation therapy aimed at localized areas to reduce tumor size or manage symptoms - Targeted therapy that attacks specific molecules involved in the growth of lymphoma cells - Immunotherapy to boost the body's immune response against cancer - Stem cell transplant in advanced or resistant cases - Supportive care to manage side effects and improve quality of life Participation in clinical trials might also be considered for access to cutting-edge therapies. As treatment plans are personalized, coordination with oncologists and hematologists is essential for optimal care.
Clinical Advice & FAQs
Billing Guidance
Is C84.45 a billable ICD-10 code?
Yes, C84.45 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.45?
Clinical documentation must specify the nature of Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of inguinal region and lower limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference